Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage - Wikidata - wikimedia - TriplyDB

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage

http://www.wikidata.org/entity/Q24202851

about

Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings Homeopathy for reducing blood loss in the third stage of labour Tranexamic acid for preventing postpartum haemorrhage Active versus expectant management for women in the third stage of labour Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis Third Stage of Labor and Acupuncture Oxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness Analysis Evaluation of in vivo effects of Oxytocin on coagulation of parturient during cesarean delivery by thromboelastography Barriers to deferred cord clamping in preterm infants.Oxytocin: taking the heat.Status of emergency obstetric care in six developing countries five years before the MDG targets for maternal and newborn health.The prevention of postpartum hemorrhage in the community.Patterns of second-line uterotonic use in a large sample of hospitalizations for childbirth in the United States: 2007-2011 Second-line uterotonics and the risk of hemorrhage-related morbidity Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial.Bedside Availability of Prepared Oxytocin and Rapid Administration After Delivery to Prevent Postpartum Hemorrhage: An Observational Study in Karnataka, India.Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda.Use of prophylactic uterotonics during the third stage of labor: a survey of provider practices in community health facilities in Sierra Leone.Incidence of immediate postpartum hemorrhages in French maternity units: a prospective observational study (HERA study)Replacement of oxytocin bolus administration by infusion: influences on postpartum outcome Acute complete uterine inversion after controlled cord traction of placenta following vaginal delivery: a case report.Management of obstetric postpartum hemorrhage: a national service evaluation of current practice in the UK.Understanding causal pathways within health systems policy evaluation through mediation analysis: an application to payment for performance (P4P) in Tanzania Role of Prophylactic Oxytocin in the Third Stage of Labor: Physiologic Versus Pharmacologically Influenced Labor and Birth.Improving the quality of maternity services in Uganda through accelerated implementation of essential interventions by healthcare professional associations.The association between the time from oxytocin cessation during labour to Cesarean delivery and postpartum blood loss: a retrospective cohort study.Association of peripartum synthetic oxytocin administration and depressive and anxiety disorders within the first postpartum year.Risk of Peripartum Hysterectomy and Center Hysterectomy and Delivery Volume.Randomized controlled trial comparing 200μg and 400μg sublingual misoprostol for prevention of primary postpartum hemorrhage.Effects of placental cord drainage in the third stage of labour: A meta-analysis.The Routine Use of Prophylactic Oxytocin in the Third Stage of Labor to Reduce Maternal Blood Loss.Lack of controlled studies investigating the risk of postpartum haemorrhage in cesarean delivery after prior use of oxytocin: a scoping review.Intramuscular oxytocin versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery (LabOR trial): study protocol for a randomised controlled trial.Effect of a High-Rate Versus a Low-Rate Oxytocin Infusion for Maintaining Uterine Contractility During Elective Cesarean Delivery: A Prospective Randomized Clinical Trial.Cost effectiveness analysis of carbetocin during cesarean section in a high volume maternity unit.Intramuscular versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery: randomised controlled trial

P2860

Q21144590-F46F0434-5DED-4672-90BC-5F8B5766DD62 Q24185904-8AD9EAAA-B4A4-4506-A8E3-A241C6C030CF Q24186371-75686FE6-B1A7-4473-A43C-974B0CD8E503 Q24186919-60C2EEF4-EC6C-41F5-9106-5F3335620845 Q24187146-397C07BC-C268-4E1A-9B55-6CC963944AE7 Q24187465-207F98CF-FBD5-4CD5-9D33-DBA1E3E46010 Q24188230-35ABD169-9F6B-4ABC-BD02-2D43D3DEF51F Q26866389-A2469222-348B-47AF-96D4-1C588A9076DD Q29353660-6A1612AD-9830-44BD-A337-558C77407834 Q33834262-35E6B369-6199-4509-A155-28D5321F0185 Q34092317-538BC514-9C9E-4358-93DB-E8C99FC138ED Q34210947-D14B37BF-4D8D-49CB-ACD5-0F93B1A91A57 Q34510283-FA963A5D-9C82-43B9-BABD-13BED7C23BE0 Q35018000-CB0653CA-783E-470D-A295-31385815093E Q35064648-92371DE1-4799-4A61-A75F-A1844F16DE3C Q35561431-D2C31331-0DD2-4A71-8353-10FF2E4861FF Q35662691-849AFE46-D28E-459F-8BA9-54AE3C91D114 Q35767820-D6397762-E600-42EA-902A-0F78578677AE Q35839057-01AFC71D-C547-4612-BF62-1826D4969067 Q35907466-B6B7FD3A-230A-4BD7-BDD4-B2DDDB3C488E Q36110591-50C204F4-B6DF-46A8-A5B7-6A3C105A0B66 Q36892289-8DFD5FA8-50F6-42E1-BF9C-C2D6D45AAC89 Q37057894-531696A9-F80E-4615-B8EA-43857456E342 Q37603672-EA9B1C7D-1A17-496A-888F-C8B1E9AFB403 Q37620897-15E3025C-B54F-449A-9714-D9754BFC82C2 Q38681098-EC9A69B6-1445-4B88-8DCE-126CEA99B494 Q38717153-DBC431AD-50D7-4369-A9E5-D5C053F4238D Q38831096-934CA2AF-5825-46DF-B1B5-97972778AB80 Q38992677-3A6951BB-B301-45B2-A005-68E4EA82C5DC Q39204770-87D88ECC-8906-44FD-8012-8AC008C149F5 Q40117688-B987839B-2753-4D11-8A5A-B908A55DFAB1 Q41203561-A17571AB-4E8E-4230-95A5-433AD92F1B2F Q42729169-C850AB18-870E-4F95-9E7C-BB5C11817AE1 Q46301140-BA543D34-8F86-41A6-A954-D54FF690A71C Q46301463-07EA9F1B-12B2-4ADB-B3D1-B97C37A3EEF5 Q46364343-E8C92B66-9E54-42DC-9B74-6352FBD4E2EB Q47805495-0968FDDA-F9A9-4BA5-B6C5-646CC250470B Q58765740-F0902B54-7246-46A4-8B9C-510981F35083

P2860

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage

http://www.wikidata.org/entity/Q24202851

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage

@ast

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage

@en

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage

@en-gb

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage

@nl

type

label

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage

@ast

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage

@en

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage

@en-gb

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage

@nl

prefLabel

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage

@ast

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage

@en

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage

@en-gb

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage

@nl

P1433

Q24202851-6326430A-9F8E-4764-A0BB-3682138ADDBC

P1476

Q24202851-3544E1CD-7C75-492F-8D40-A8AFDB6B9891

P2093

Q24202851-AD7B5D2F-C4D5-424C-8FDC-4A0AAF42EA4D

Q24202851-BC305F06-5490-4223-A285-4C440A759C08

Q24202851-CB3AB5B6-D573-4FF2-BB90-3C86DEE0CD94

P2860

Q24202851-051EDBB5-FB22-4A42-8C28-8E233E5C38BA

Q24202851-0E8960CA-1331-4399-9F28-8A45EDC75C5F

Q24202851-19EDA8EA-3388-4397-9440-09ECC3A1717A

Q24202851-210F1E5F-B1ED-44FD-B22E-33AD46669304

Q24202851-30E4E818-329B-4F9B-9487-96F9D0831915

Q24202851-3398B624-FF52-404E-9EEA-4596CCF33BD4

Q24202851-3E51EB8C-A0DB-44D9-94D1-278F2FC97519

Q24202851-49F1B038-79D9-4D8D-A302-87F5B96F61BF

Q24202851-503AEBDB-A98D-4426-9FEB-9F746D82AAD1

Q24202851-53F70B0D-7B22-43A5-AAA7-3F73A1C955B3

P304

Q24202851-E900353D-747B-45C7-8DCE-1B47B9110E9C

P31

Q24202851-9B60182F-4F71-4156-B4DB-064ACBDB07D5

Q24202851-de30d6bd-2f2e-4615-ab5e-b9571885975b

P3181

Q24202851-6CEF180C-8429-46EA-995A-28A8AAB90615

P356

Q24202851-057B918B-539C-4E39-96F7-A8E45827E8B3

P407

Q24202851-A86FF6FD-12A6-44CB-9E8F-ADCA70139F0D

P433

Q24202851-BF06381F-EB9A-47D3-AC63-74E6562F79E2

P577

Q24202851-C5FA4EA7-7FEF-4D7E-9355-38A1567C42FE

P698

Q24202851-F270350D-3C28-4597-859B-772754D5CA27

P921

Q24202851-56841499-B21B-49EA-9117-B770E3FB72EB

Q24202851-679C1EF6-ECB7-48C2-81D4-E61E5718F1D5

Q24202851-BECBCCB6-1CF0-4D46-B7F9-7C4656A59AE3

Q24202851-C7BC0F2C-C5EE-4384-89F2-7E0CFD71D3C3

Q24202851-E9E23675-CB48-4E39-A004-DF54F7B63506

P3181

P356

14651858.CD001808.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage

@en

P2093

Amanda M Cotter

http://www.w3.org/2001/XMLSchema#string

Gina Westhoff

http://www.w3.org/2001/XMLSchema#string

Jorge E Tolosa

http://www.w3.org/2001/XMLSchema#string

P2860

Umbilical vein injection for the routine management of third stage of labour

Prostaglandins for preventing postpartum haemorrhage

Active versus expectant management for women in the third stage of labour

Timing of prophylactic uterotonics for the third stage of labour after vaginal birth

Prophylactic use of ergot alkaloids in the third stage of labour

Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour

Bias in meta-analysis detected by a simple, graphical test

A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints

Active versus expectant management in the third stage of labour.

Umbilical vein injection for management of retained placenta.

P304

CD001808

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

892896

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/14651858.CD001808.PUB2

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24173606

http://www.w3.org/2001/XMLSchema#string

P921

internal bleeding

maternal health

postpartum period